Deal of the year in biotech | SRPT Message Board Posts

SRPT   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  14034 of 14253  at  12/24/2019 11:45:49 AM  by

schmiggins


 In response to msg 14031 by  bagbest
view thread

Re: Deal of the year in biotech

It look like there's a plan to let Roche take on the RNA side of things if all goes well with GT, I suppose. Starting with DMD - the PMOs and the PPMOs.

But the PPMO can take us out of rare and into common diseases. Big populations here and abroad. Naturally that's where a Roche would fit in (both abroad and US). And other big players as well if that's how it plays out.

What ARE we doing in our PPMO RNA researches? What IS Gilmore up to? That's going to be interesting.The DMD PPMOs will get that ball rolling, but once they are out of hiding and working in the DMD kids then attention will turn to what THEY can do. Which I think is a lot, of course!


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 257
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






Financial Market Data provided by
.


Loading...